![logo](/logos/000919.SZ.webp)
Jinling Pharmaceutical Company Limited
SZSE:000919.SZ
8.51 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Jinling Pharmaceutical Company Limited |
Symbool | 000919.SZ |
Munteenheid | CNY |
Prijs | 7.85 |
Beurswaarde | 4,012,417,600 |
Dividendpercentage | 1.39% |
52-weken bereik | 7.17 - 12 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yang Wang |
Website | https://www.jlyy000919.com |
An error occurred while fetching data.
Over Jinling Pharmaceutical Company Limited
Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)